Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Biofil Chemicals & Pharmaceuticals Financial Results

Biofil Chemicals reported annual revenue of ₹28.40 Crore for FY26. The Board approved audited results with an unmodified auditor opinion during its May 2026 meeting.

Key figures
Value₹28.40 Cr
Source

BSE filing, NSE: BIOFILCHEM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Biofil Chemicals & Pharmaceuticals Ltd: key numbers

Share price
₹29.26
Market cap
₹47.62 Cr
Revenue (annual)
₹28.40 Cr
Net profit (annual)
₹2.79 Cr
P/E (TTM)
98.4×Sector 46.1×
Promoter holding
46.79%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Biofil Chemicals & Pharmaceuticals Ltd

All →

Other financial results announcements

All →